ArticleThe patient2026
Designing National Programmes for Expanded Carrier Screening: Results from a Discrete-Choice Experiment in Singapore.
Article in The patient, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
BACKGROUND AND
objectiveCarrier screening for inherited genetic disorders can reduce the burden of conditions that lead to morbidity and mortality. National carrier screening programme uptake may depend on population preferences for screening. In this study, we aimed to determine how expanded carrier screening in Singapore should be provided based on population stated preferences.
methodsWe elicited stated preferences for the design of a national carrier screening programme with seven attributes from 500 Singaporeans aged 18-54 years. A discrete choice experiment was applied using three blocks of ten choice tasks with three alternatives per task, including the choice to opt out of screening. The mixed multinomial logit model was used to analyse preferences. We assessed willingness-to-pay for screening and predicted programme uptake for a range of copayments, and estimated national budget impacts for different programme implementations.
resultsRespondents showed preferences for lower costs, a wider range of diseases included in the panel and shorter wait times. Predicted uptake ranged from 85% [95% confidence interval 83-87] to 90% [88-92] for hypothetical basic and utility-maximising screening programmes, respectively, with no copayments. This declined to 61% [56-66] and 69% [65-73], respectively, for copayments of $1200 per tested couple. Budget impact depended upon policy package, population eligibility, copayments and couples' decision-making processes, but was unlikely to exceed $13.1 m [$11.0-$15.7] per year for a utility-maximising programme unless expanded beyond pre-conception married couples.
conclusionsThere were strong but heterogeneous preferences for expanded carrier screening in the Singaporean general population, with particularly strong preferences for more comprehensive panels of disorders. Accordingly, providing a selection of screening packages may increase programme uptake and support family planning while improving affordability.
Identifiers
42814378What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.